|
KDM2A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.521700E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.278300E-02 |
| Normal-vs-Stage2 |
6.431800E-02 |
| Normal-vs-Stage3 |
7.384800E-04 |
| Normal-vs-Stage4 |
6.152000E-04 |
| Stage1-vs-Stage2 |
8.054000E-01 |
| Stage1-vs-Stage3 |
4.744500E-02 |
| Stage1-vs-Stage4 |
4.301900E-02 |
| Stage2-vs-Stage3 |
2.882800E-01 |
| Stage2-vs-Stage4 |
1.876780E-01 |
| Stage3-vs-Stage4 |
6.483600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.504200E-03 |
| Normal-vs-AfricanAmerican |
7.342300E-02 |
| Normal-vs-Asian |
1.888780E-01 |
| Caucasian-vs-AfricanAmerican |
8.549800E-01 |
| Caucasian-vs-Asian |
3.524000E-01 |
| AfricanAmerican-vs-Asian |
4.317600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.075200E-03 |
| Normal-vs-Female |
6.044800E-03 |
| Male-vs-Female |
6.510200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.498200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.286130E-02 |
| Normal-vs-Age(61-80Yrs) |
3.579300E-04 |
| Normal-vs-Age(81-100Yrs) |
3.286000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.647200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.703700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.136200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.471960E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.940400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.261000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.820600E-03 |
| Classical-VS-Follicular |
2.231600E-04 |
| Classical-VS-Other |
3.743200E-01 |
| Classical-VS-Normal |
8.768300E-02 |
| Tall-VS-Follicular |
8.389400E-01 |
| Tall-VS-Other |
6.157800E-01 |
| Tall-VS-Normal |
5.832700E-04 |
| Follicular-VS-Other |
7.409200E-01 |
| Follicular-VS-Normal |
1.213550E-04 |
| Other-VS-Normal |
1.428550E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.922000E-03 |
| Normal-vs-N1 |
6.160000E-04 |
| N0-vs-N1 |
1.920630E-01 |
|
|
